MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Demographic Characteristics of Women with Primary Parkinsonism

    E. Tharp, J. Martinez-Lemus, J. Suescun, M. Schiess (Houston, USA)

  • Demographic Features, QTc Interval and Psychosis in Military Veterans with Parkinson’s disease (PD)

    A. Sarwar, P. Bigner (Houston, USA)

  • Dentatorubral–Pallidoluysian Atrophy (DRPLA) : A case series of nine patients from western India

    K. Bavdhankar, P. Agarwal, N. Jain, S. Kothari, A. Soni, S. Kharat, A. Shah, S. Jagtap (Mumbai, India)

  • Depression and Social Engagement in Community-Dwelling Older Adults with Parkinsonism

    M. Roy, Md, D. Gonzalez, Phd, M. Tosin, Phd, C. Goetz, Md, R. Wilson, Phd (Chicago, USA)

  • Depressive Symptomatology in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia. Descriptive Study of the ESDEPARK Scale.

    P. Andrea Gutiérrez-Lenis, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospina-Otalvaro, A. Lucumi Moreno, M. Cañas-Lucendo, D. Reyes-Torres, L. Maria Villegas-Trujillo, S. Ordoñez-Cure, M. Alejandra Vásquez-Martínez (Zaragoza, Spain)

  • Description Genotype/phenotype of patients with Parkinson’s disease. Report of an Argentinean cohort included in the LARGE PD Consortium.

    M. Espindola, N. Gonzalez Rojas, G. da Prat, M. Cesarini, J. Etcheverry, I. Mata, C. Perandones, E. Gatto (Cleveland, USA)

  • Description possible enviromental exposure in AMS Latin America population

    M. Cesarini, N. Gonzalez Rojas, M. Espindola, G. da Prat, JL. Etcheverry, E. Gatto (Buenos Aires, Argentina)

  • Design and Outcome Measures of BRAVE, a Phase 3 Study of Omaveloxolone in Pediatric Patients With Friedreich Ataxia

    D. Lynch, M. Delatycki, M. França, A. Durr, E. Bertini, S. Perlman, A. Arizpe, R. Domingo-Horne, S. Fradette, S. Sinks, M. Murai, N. Folschweiller (Philadelphia, USA)

  • Design of ORCHESTRA Study: Practical Experiences With Foslevodopa/Foscarbidopa Treatment in Advanced Parkinson’s Disease

    A. Johansson, E. Pekkonen, L. Dorresteijn, P. Schwingenschuh, J. Szász, L. Bergmann, M. O'Meara, J. Parra, M. Südmeyer (Helsinki, Finland)

  • Design of the Phase 2, Double-Blind, Placebo-Controlled, Multicenter Study Investigating the Efficacy and Safety of ACP-204, a Novel 5-HT2A Inverse Agonist, in Adults With Lewy Body Dementia Psychosis

    R. Nunez, S. Friend, B. Howell, S. Pathak, B. Dirks, X. Feng, V. Abler (San Diego, USA)

  • « Previous Page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley